FDA lets Ascent reprocess AcuNav catheters four times:
This article was originally published in Clinica
Executive Summary
The FDA has given Ascent Healthcare Solutions US market clearance to increase the number of times that it can reprocess the AcuNav ultrasound catheter from two to up to four times. "Cath labs that reprocess the catheter four times, rather than buying original product, will reduce their cost per procedure by an average of $1,000." said Rick Ferreira, the Phoenix, Arizona firm's COO. "That is a valuable investment that goes straight to their bottom line."